10-Q: Allied Corp. Reports Q1 2024 Results with Revenue Decline and Continued Losses
Quarterly Report
Allied Corp. reports a net loss of $836,673 for the quarter ended November 30, 2023, with a significant decrease in revenue compared to the same period last year.
Summary
- Allied Corp. reported a net loss of $836,673 for the three months ended November 30, 2023, compared to a net loss of $1,309,541 for the same period in 2022.
- The company's revenue decreased to $19,039 in Q1 2024 from $69,625 in Q1 2023.
- Gross margin also decreased to $17,036 from $43,667 year-over-year.
- Operating expenses were $760,842 for the quarter, down from $1,242,966 in the prior year.
- The company has a working capital deficit of $8,699,414 as of November 30, 2023.
- Allied Corp. is relying on equity and debt financing to fund operations and future development.
- The company's ability to continue as a going concern is dependent on its ability to raise sufficient financing.
Sentiment
Score: 3
Explanation: The document presents a concerning financial picture with significant revenue decline, substantial losses, a large working capital deficit, and defaults on debt. While there are some positive aspects like reduced operating expenses, the overall sentiment is negative due to the company's financial instability and reliance on future financing.
Positives
- Operating expenses decreased significantly year-over-year, indicating some cost control measures.
- The net loss decreased compared to the same period last year, although still substantial.
Negatives
- The company experienced a significant decrease in revenue year-over-year.
- The company has a substantial working capital deficit, raising concerns about its ability to meet short-term obligations.
- The company's cash balance has decreased significantly from the previous quarter.
- The company has a large amount of debt in the form of secured convertible notes payable.
- The company has defaulted on all of its convertible notes and is in the process of amending the maturity dates and conversion prices.
Risks
- The company's ability to continue as a going concern is dependent on its ability to raise sufficient financing.
- The company has a significant working capital deficit and may struggle to meet its financial obligations.
- The company is reliant on equity and debt financing, which may not be available on favorable terms.
- The company has defaulted on all of its convertible notes, which could lead to further financial strain.
- The company is involved in legal proceedings regarding a land lease and ownership of buildings in Nevada, which could result in further losses.
Future Outlook
The company's ability to continue as a going concern is dependent on its ability to raise sufficient financing to develop a profitable business. Management intends on financing its operations and future development activities largely from the sale of equity securities and debt financing with some additional funding from other traditional financing sources, including related party loans until such time that funds provided by future planned operations are sufficient to fund working capital requirements.
Management Comments
- Management intends on financing its operations and future development activities largely from the sale of equity securities and debt financing with some additional funding from other traditional financing sources, including related party loans until such time that funds provided by future planned operations are sufficient to fund working capital requirements.
- Our management team believes that having control over our supply chain should enable us to provide a consistent, rolling-harvest supply to the global cannabis community.
- Allied Corps commitment to building and maintaining strong relationships with its partners and customers around the world has been a driving force behind its recent successes.
Industry Context
The company operates in the medical cannabis industry, which is subject to evolving regulations and market conditions. The company's focus on low-cost production in Colombia and international distribution is a strategy to gain a competitive advantage. However, the company faces risks related to the legality of cannabis in the United States and the evolving regulatory landscape in Colombia.
Comparison to Industry Standards
- The company's revenue of $19,039 is significantly lower than many established cannabis companies, indicating a very early stage of commercialization.
- The company's gross margin of $17,036 is also low, suggesting challenges in achieving profitability.
- The company's operating expenses of $760,842 are high relative to its revenue, indicating a need for cost control.
- The company's working capital deficit of $8,699,414 is a significant concern, as many cannabis companies struggle with cash flow and require ongoing capital raises.
- The company's reliance on convertible notes and equity financing is common in the cannabis industry, but the high level of debt and defaults on notes are concerning.
- Compared to companies like Canopy Growth or Aurora Cannabis, which have established brands and distribution networks, Allied Corp. is in a much earlier stage of development and faces significant challenges in achieving profitability and sustainability.
Legal Proceedings
- The company is involved in legal proceedings regarding a land lease and ownership of buildings in Nevada.
- The company filed a complaint in the Eighth Judicial District Court in Clark County, Nevada seeking injunctive relief to terminate a trustees sale or alternatively money damages.
- The company filed suit, seeking a declaration of the Companys ownership of the buildings as the buildings were personal property and not a part of the real property.
Related Party Transactions
- The company has significant amounts due to related parties, including directors and officers.
- The company shares certain administrative resources with companies related by common management and directors.
Stakeholder Impact
- Shareholders are at risk due to the company's financial instability and reliance on future financing.
- Employees may be affected by potential cost-cutting measures or operational changes.
- Creditors are at risk due to the company's defaults on convertible notes.
- Customers may be affected by potential disruptions in the company's operations.
Next Steps
- The company needs to secure additional financing to continue operations.
- The company needs to address the defaults on its convertible notes.
- The company needs to resolve the legal proceedings regarding the land lease and building ownership in Nevada.
- The company needs to improve its revenue generation and cost control measures.
Key Dates
| Date | Description |
|---|---|
| 2013-02-03 | Allied Corp. was incorporated in the State of Nevada. |
| 2018-09-13 | Date of incorporation of AM Biosciences, treated as the acquirer in a reverse takeover. |
| 2019-07-01 | The Company changed its name to Allied Corp. |
| 2019-08-29 | Allied Corp. entered into a Share Purchase Agreement to acquire Baleno Ltd. |
| 2019-09-10 | The Company was acquired in a reverse takeover transaction. |
| 2020-02-17 | The Company closed and completed the acquisition of Medicolombia (now Allied Colombia). |
| 2020-02-18 | The Company acquired all the issued and outstanding share capital of Allied Colombia S.A.S. |
| 2020-05-29 | The Company made a payment at commencement date for a financing agreement. |
| 2020-06-20 | The Company began making monthly interest payments for a financing agreement. |
| 2020-07-01 | The Company entered into amendments to convertible notes. |
| 2020-07-20 | Maturity date of convertible notes issued on January 23, 2020. |
| 2020-09-29 | The Company issued a convertible note. |
| 2020-10-26 | The Company issued a convertible note. |
| 2020-11-01 | The Company entered into amendments to convertible notes. |
| 2020-11-11 | The Company issued a convertible note. |
| 2020-12-02 | The Company issued a convertible note. |
| 2021-01-07 | The Company issued a convertible note. |
| 2021-03-26 | The Company issued a convertible note. |
| 2021-03-30 | Allied US Products LLC entered into a contingent asset purchase agreement. |
| 2021-03-31 | The Company entered into amendments to convertible notes. |
| 2021-04-29 | The Company issued a convertible note. |
| 2021-06-01 | The Company entered into amendments to convertible notes. |
| 2021-07-25 | The Company issued a convertible note. |
| 2021-08-10 | The Company entered into a lease for additional land in Colombia. |
| 2021-10-01 | The Company entered into amendments to convertible notes. |
| 2021-10-25 | The Company issued a convertible note. |
| 2021-11-01 | The Company entered into amendments to convertible notes. |
| 2021-12-17 | The Company entered into a financing agreement to finance an equipment purchase. |
| 2021-12-23 | The Company issued a convertible note. |
| 2021-12-27 | The Company entered into an amendment agreement for a loan. |
| 2022-01-11 | The Company issued a convertible note. |
| 2022-01-20 | The Company began making monthly payments for a loan. |
| 2022-01-31 | The Company issued a convertible note. |
| 2022-03-29 | The Company issued a convertible note. |
| 2022-03-31 | The Company entered into amendments to convertible notes. |
| 2022-06-16 | The Company issued a convertible note. |
| 2022-09-21 | The Company issued shares of common stock. |
| 2022-09-30 | The Company defaulted on several convertible notes. |
| 2022-10-07 | The Company issued shares of common stock. |
| 2022-11-28 | The Company issued a convertible note. |
| 2022-12-01 | The Company issued a convertible note. |
| 2022-12-07 | The Company issued a convertible note. |
| 2022-12-13 | A status conference was held for legal proceedings in Nevada. |
| 2023-02-28 | The Company issued a convertible note. |
| 2023-05-17 | The Company issued a convertible note. |
| 2023-08-31 | The Company terminated a lease. |
| 2023-09-05 | The Company issued shares of common stock. |
| 2023-09-17 | The Company defaulted on a convertible note. |
| 2023-10-20 | The Company issued shares of common stock. |
| 2023-11-30 | End of the reporting period for this quarterly report. |
| 2023-12-01 | The Company issued shares of common stock. |
| 2023-12-04 | The Company issued a secured convertible note. |
| 2023-12-20 | The Company modified the exercise prices and expiry dates for previously granted and unexercised options. |
| 2024-01-16 | Date of the filing of this quarterly report. |
Keywords
cannabis, medical cannabis, financial results, quarterly report, convertible notes, working capital, net loss, revenue, operating expenses, debt, Colombia, financing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.